Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Lexeo Therapeutics

Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 22, 2026

Sentiment
20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Lexeo Therapeutics, Inc. (LXEO) announced a series of strategic transactions to expand its presence in Friedreich ataxia (FA), including a definitive agreement to acquire privately held clinical-stage company Ajax Therapeutics, Inc. The acquisition adds multiple…
Impact: Lexeo is the acquirer and central actor, expanding its Friedreich ataxia portfolio through the Mantle acquisition and three research collaborations. The deals broaden its pipeline and technology platform while maintaining cash runway into 2028, supporting a modestly positive market reaction.
Sep 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Lexeo Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.